MicroRNA-223 expression is upregulated in insulin resistant human adipose tissue

Journal of Diabetes Research

Volumn 2015, Issue , 2015, Pages

  Chuang, Tung Yueh ^a   Wu, Hsiao Li ^a   Chen, Chen Chun ^b   Gamboa, Gloria Mabel ^a   Layman, Lawrence C ^a,b   Diamond, Michael P ^a   Azziz, Ricardo ^a   Chen, Yen Hao ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b AUGUSTA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; MICRORNA 223; MICRORNA 93; PRASTERONE SULFATE; PROLACTIN; TESTOSTERONE; THYROTROPIN; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; GLUCOSE BLOOD LEVEL; MICRORNA; MIRN223 MICRORNA, HUMAN; MIRN93 MICRORNA, HUMAN; SLC2A4 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

3' UNTRANSLATED REGION; ABDOMINAL FAT; ADIPOCYTE; ADULT; ARTICLE; BODY MASS; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HAIR GROWTH; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; METABOLIC DISORDER; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; UPREGULATION; ADIPOSE TISSUE; ANALYSIS; BIOPSY; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

3' UNTRANSLATED REGIONS; ADIPOCYTES; ADIPOSE TISSUE; ADULT; BIOPSY; BLOOD GLUCOSE; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORTER TYPE 4; HUMANS; INSULIN; INSULIN RESISTANCE; MICRORNAS; MIDDLE AGED; POLYCYSTIC OVARY SYNDROME; REAL-TIME POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84939143918     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2015/943659     Document Type: Article

References (40)

1. M. Malumbres, "MiRNAs and cancer: an epigenetics view, " Molecular Aspects of Medicine, vol. 34, no. 4, pp. 863-874, 2013.
2. G. Müller, M. Schneider, G. Biemer-Daub, and S. Wied, "Microvesicles released from rat adipocytes and harboring glycosylphosphatidylinositol-anchored proteins transfer RNA stimulating lipid synthesis, " Cellular Signalling, vol. 23, no. 7, pp. 1207-1223, 2011.
3. H. Zhu, S. -C. Ng, A. V. Segr et al. , "TheLin28/let-7 axis regulates glucose metabolism, " Cell, vol. 147, no. 1, pp. 81-94, 2011.
4. C. Esau, S. Davis, S. F. Murray et al. , "miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting, " Cell Metabolism, vol. 3, no. 2, pp. 87-98, 2006.
5. A. He, L. Zhu, N. Gupta, Y. Chang, and F. Fang, "Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes, "Molecular Endocrinology, vol. 21, no. 11, pp. 2785-2794, 2007.
6. M. N. Poy, L. Eliasson, J. Krutzfeldt et al. , "A pancreatic isletspecific microRNAregulates insulin secretion, " Nature, vol. 432, no. 7014, pp. 226-230, 2004.
7. B. M. Herrera, H. E. Lockstone, J. M. Taylor et al. , "Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes, " Diabetologia, vol. 53, no. 6, pp. 1099-1109, 2010.
8. H. Y. Ling, H. S. Ou, S. D. Feng et al. , "Changes in microRNA (miR) profile and effects of miR-320 in insulin-resistant 3t3-l1 adipocytes, " Clinical and Experimental Pharmacology and Physiology, vol. 36, no. 9, pp. e32-e39, 2009.
9. R. Azziz, E. Carmina, D. Dewailly et al. , "The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report, " Fertility and Sterility, vol. 91, no. 2, pp. 456-488, 2009.
10. T. P. Ciaraldi, V. Aroda, S. Mudaliar, R. J. Chang, and R. R. Henry, "Polycystic ovary syndrome is associated with tissuespecific differences in insulin resistance, " Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 1, pp. 157-163, 2009.
11. Y. H. Chen, S. Heneidi, J. M. Lee et al. , "miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance, " Diabetes, vol. 62, no. 7, pp. 2278-2286, 2013.
12. H. Lu, R. J. Buchan, and S. A. Cook, "MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism, " Cardiovascular Research, vol. 86, no. 3, pp. 410-420, 2010.
13. R. Azziz, K. S. Woods, R. Reyna, T. J. Key, E. S. Knochenhauer, and B. O. Yildiz, "The prevalence and features of the polycystic ovary syndrome in an unselected population, " Journal of Clinical Endocrinology andMetabolism, vol. 89, no. 6, pp. 2745-2749, 2004.
14. R. Azziz, W. Y. Chang, F. Z. Stanczyk, and K. Woods, "Effect of bilateral oophorectomy on adrenocortical function in women with polycystic ovary syndrome, " Fertility and Sterility, vol. 99, no. 2, pp. 599-604, 2013.
15. R. Azziz, "Fat biopsy procedure with Dr. Ricardo Azziz, " in Mcgwebcontent, Georgia Health Sciences University, Augusta, Ga, USA, 2012, http://www.youtube.com/.
16. M. J. Neville, J. M. Collins, A. L. Gloyn, M. I. McCarthy, and F. Karpe, "Comprehensive human adipose tissue mRNA and microRNA endogenous control selection for quantitative realtime-PCR normalization, " Obesity, vol. 19, no. 4, pp. 888-892, 2011.
17. Y. H. Chen, S. Heneidi, J. M. Lee et al. , "miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of Polycystic Ovary Syndrome patients and women with insulin resistance, " Diabetes, vol. 62, no. 7, pp. 2278-2286, 2013.
18. D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, "Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man, " Diabetologia, vol. 28, no. 7, pp. 412-419, 1985.
19. H. Ruan and H. F. Lodish, "Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha, " Cytokine and Growth Factor Reviews, vol. 14, no. 5, pp. 447-455, 2003.
20. P. R. Shepherd and B. B. Kahn, "Glucose transporters and insulin action: implications for insulin resistance and diabetes mellitus, "The New England Journal of Medicine, vol. 341, no. 4, pp. 248-257, 1999.
21. M. J. Thomson, M. G. Williams, and S. C. Frost, "Development of insulin resistance in 3T3-L1 adipocytes, " The Journal of Biological Chemistry, vol. 272, no. 12, pp. 7759-7764, 1997.
22. E. D. Abel, O. Peroni, J. K. Kim et al. , "Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver, " Nature, vol. 409, no. 6821, pp. 729-733, 2001.
23. E. Tozzo, P. R. Shepherd, L. Gnudi, and B. B. Kahn, "Transgenic GLUT-4 overexpression in fat enhances glucose metabolism: preferential effect on fatty acid synthesis, " The American Journal of Physiology-Endocrinology and Metabolism, vol. 268, no. 5, pp. E956-E964, 1995.
24. Y. Xu, H. Jin, X. Yang et al. , "MicroRNA-93 inhibits inflammatory cytokine production in LPS-stimulated murine macrophages by targeting IRAK4, " FEBS Letters, vol. 588, no. 9, pp. 1692-1698, 2014.
25. G. Zhuang, C. Meng, X. Guo et al. , "A novel regulator of macrophage activation: MiR-223 in obesity-associated adipose tissue inflammation, " Circulation, vol. 125, no. 23, pp. 2892-2903, 2012.
26. J. M. Olefsky and C. K. Glass, "Macrophages, inflammation, and insulin resistance, "Annual Reviewof Physiology, vol. 72, pp. 219-246, 2009.
27. J. A. Pulikkan, V. Dengler, P. S. Peramangalam et al. , "Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia, " Blood, vol. 115, no. 9, pp. 1768-1778, 2010.
28. F. Petrocca, R. Visone, M. R. Onelli et al. , "E2F1-regulated microRNAs impair TGFβ-dependent cell-cycle arrest and apoptosis in gastric cancer, " Cancer Cell, vol. 13, no. 3, pp. 272-286, 2008.
29. M. Haneklaus, M. Gerlic, L. A. J. ONeill, and S. L. Masters, "MiR-223: infection, inflammation and cancer, " Journal of Internal Medicine, vol. 274, no. 3, pp. 215-226, 2013.
30. E. M. Pinatel, F. Orso, E. Penna et al. , "miR-223 is a coordinator of breast cancer progression as revealed by bioinformatics predictions, " PLoS ONE, vol. 9, no. 1, Article ID e84859, 2014.
31. S. Li, Z. Li, F. Guo et al. , "MiR-223 regulatesmigration and invasion by targeting Artemin in human esophageal carcinoma, " Journal of Biomedical Science, vol. 18, no. 1, article 24, 2011.
32. J. Li, Y. Guo, X. Liang et al. , "MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4, " Journal of Cancer Research and Clinical Oncology, vol. 138, no. 5, pp. 763-774, 2012.
33. Y. Wei, J. Yang, L. Yi et al. , "MiR-223-3p targeting SEPT6 promotes the biological behavior of prostate cancer, " Scientific Reports, vol. 4, article 7546, 2014.
34. L. Du, J. J. Schageman, M. C. Subauste et al. , "miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1, " Molecular Cancer Research, vol. 7, no. 8, pp. 1234-1243, 2009.
35. X. Chen, S. Chen, Y. L. Xiu, K. X. Sun, Z. H. Zong, and Y. Zhao, "RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression, " Molecular Cancer, vol. 14, article 31, 2015.
36. K. Ohta, H. Hoshino, J. Wang et al. , "MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A, " Oncotarget, vol. 6, no. 5, pp. 3211-3224, 2015.
37. X. Lyu, W. Fang, L. Cai et al. , "TGFbetaR2 is a major target of miR-93 in nasopharyngeal carcinoma aggressiveness, " Molecular Cancer, vol. 13, no. 1, article 51, 2014.
38. B. Singh, A. M. Ronghe, A. Chatterjee, N. K. Bhat, and H. K. Bhat, "MicroRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis, " Carcinogenesis, vol. 34, no. 5, pp. 1165-1172, 2013.
39. J. Long, Y. Wang, W. Wang, B. H. J. Chang, and F. R. Danesh, "Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions, " The Journal of Biological Chemistry, vol. 285, no. 30, pp. 23457-23465, 2010.
40. L. Shi, B. Fisslthaler, N. Zippel et al. , "MicroRNA-223 antagonizes angiogenesis by targeting beta1 integrin and preventing growth factor signaling in endothelial cells, " Circulation Research, vol. 113, no. 12, pp. 1320-1330, 2013.